Jake K. Klaisner
Jake Klaisner is a principal and consulting actuary with the Milwaukee office of Milliman. He joined the firm in 2013.
Experience
Jake has over a decade of healthcare experience in managed care pricing, financial reporting, strategic analysis, regulatory analysis, and compliance. His areas of expertise include Medicare Part D, prescription drug analytics, and pharmaceutical manufacturer market access strategy.
In the Medicare market, Jake has assisted Medicare Part D plans with bid preparation and strategic analyses. He also conducts firm-wide research in formulary analytics, PDP market dynamics, and Part D risk score analysis. He is a key contributor to Milliman's Part D research efforts.
In the pharmacy space, Jake has worked with pharmaceutical manufacturers, industry organizations, and government entities, with emphasis on the Medicare Part D benefit. His recent work includes helping clients with payment strategy, market access, and regulatory issues.
- Charting the IRA’s Drug Price Negotiation: Navigating the Waters of Stakeholder Impacts. SOA webinar, November 2023.
- Anti-Obesity Medication Coverage and Management, Digital Health New York – Obesity Work Group, October 2023.
- Capitalizing on Uncertainty: Winning Strategies with the Inflation Reduction Act. SOA Health Meeting, June 2023.
- Post-IRA Reality and A Way Forward, No Patient Left Behind webinar, September 2022.
- The Inflation Reduction Act: What’s changing in healthcare? Milliman webinar, August 2022.
- Hot Topics Roundtable: Changes in Part D and Part B Drugs – Minimizing Risks and Costs, RISE – Part D Master Class, August 2022.
- Ever-Impending Reform: A Look at Potential Part D Redesign. CCA webinar, February 2022.
- Fellow, Society of Actuaries
- Member, Academy of Actuaries
- BBA, Actuarial Science, Risk Management and Insurance, and Economics, University of Wisconsin